News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AxioMed Spine Corporation Initiates Pivotal Study


9/29/2008 8:35:16 AM

GARFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--AxioMed® Spine Corporation (www.axiomed.com), focused on next-generation devices for the restoration of spinal function, announces the initiation of its pivotal clinical study of the Freedom® Lumbar Disc, an elastomeric total disc replacement device. This multi-center pivotal trial in the US and EU follows Food and Drug Administration (FDA) approval of the company’s Investigational Device Exemption (IDE) application and successful completion of enrollment for AxioMed’s multi-center pilot clinical study in the EU.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES